Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2781-2787

  Ichikawa, Hiroshi T ^a   Williams, Lucas P ^a   Segal, Benjamin M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; INTERLEUKIN 12; OLIGONUCLEOTIDE; PROTEOLIPID PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFECTION; LYMPH NODE CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STEADY STATE; T LYMPHOCYTE; TH1 CELL;

EID: 0036721808     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2781     Document Type: Article

References (66)

1. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: Mechanisms of selection of the self-reactive repertoire
2. Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules
3. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
4. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls
5. A novel candidate autoantigen in a multiplex family with multiple sclerosis: Prevalence of T-lymphocytes specific for an MBP epitope unique to myelination
6. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity
7. "Classic" myelin basic proteins are expressed in lymphoid tissue macrophages
8. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis
9. The human myelin basic protein gene is included within a 179-kilobase transcription unit: Expression in the immune and central nervous systems
10. Expression of the myelin proteolipid protein gene in the human fetal thymus
11. Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo
12. Thymic expression of myelin basic protein (MBP): Activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP
13. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats
14. Role of antigen-presenting cells in mediating tolerance and autoimmunity
15. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
16. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
17. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
18. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
19. In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes
20. Constitutive class I-restricted exogenous presentation of self antigens in vivo
21. The danger model: A renewed sense of self
22. Influence of infection on exacerbations of multiple sclerosis
23. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
24. Clinical viral infections and multiple sclerosis
25. Viruses, cytokines, antigens, and autoimmunity
26. Multiple sclerosis associated with sinusitis: Case-controlled study in general practice
27. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders
28. Viral infection in patients with multiple sclerosis and HLA-DR matched controls
29. + T cells to cause immunopathology
30. Infection breaks T-cell tolerance
31. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA
32. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
33. + dendritic cells
34. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
35. + T-helper and a T-killer cell
36. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
37. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12
38. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
39. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α
40. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
41. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
42. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction
43. IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE)
44. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
45. IL-12 unmasks latent autoimmnune disease in resistant mice
46. Microbial products induce autoimmune disease by an IL-12-dependent pathway
47. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
48. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo
49. The role of IL-12 in the induction of organ-specific autoimmune diseases
50. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12: Preferential expansion of interferon-γ-producing cells and increased expression of macrophageassociated inducible nitric oxide synthase as immunomodulatory mechanisms
51. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide
52. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
53. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
54. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching
55. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
56. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis
57. CD28/B7 system of T cell costimulation
58. The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration
59. + T cells
60. Tolerance, danger, and the extended family
61. Role of bacterial infection in exacerbation of multiple sclerosis
62. Prospective study on the relationship between infections and multiple sclerosis exacerbations
63. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis
64. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
65. The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis
66. Role of interleukin 12 and costimulators in T cell anergy in vivo